It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
According to medical experts, the genetic material given to the patient in this new drug is not able to replicate and poses virtually no health risk. According to the CDC, the trial was doled out 200 people but only proved effective to those with white skin and some scientists believe high levels of melanin in black people may somehow be affecting the sample.
A CDC spokesman said: "Early tests of an experimental drug, which would effectively combat the spread of ebola, have proved successful only in those with white skin. We are working diligently to improve the sample to be able to help all those who are in need.”
But, of course, there are no credible reports that support the article's claim that any of the new treatments will only work on people with white skin.
In fact, the report is an extremely poor taste - and decidedly inept - attempt at satirical humour that comes courtesy of the fake-news website TheNewsNerd. The site considers itself satirical and includes the following disclaimer in the footer of its pages:
The stories posted on TheNewsNerd are for entertainment purposes only. The stories may mimic articles found in the headlines, but rest assured they are purely satirical.
originally posted by: worldwatcher
a reply to: Char-Lee
thanks Char- Lee
I really hope it's a hoax!!!!!! Because the implications of not being a hoax is frightening!!!!!!!
The early human tests are being conducted at the NIH Clinical Center in Bethesda, Md. The initial trial includes 20 adults, who received the vaccine in differing doses. Some results will likely come by year's end.
Are there other companies developing experimental treatments or vaccines?
Two other companies, Tekmira and Biocryst Pharmaceuticals, receive funding from the Department of Defense's Defense Threat Reduction Agency and have therapeutic candidates for Ebola in early development. The Department of Defense is working with a company called Newlink to develop an Ebola vaccine candidate. BioCryst, with NIH support, is working to develop an antiviral drug to treat Ebola virus that is expected to begin Phase 1 testing later this year.
originally posted by: dollukka
Spanish priest who also got vaccine and died so its not like it worked in all whites. Atm white folks who have received the vaccine have been medical personnel which also gives a clue that they most likely also have had better diet and better health condition in general. Spanish priest were older and his system weaker.